A Study of JS026 and JS026 Together With JS016 for Treatment of COVID-19

JS026 - Shanghai Junshi Biosci

etesevimab (JS016) - Chinese Academy of Sciences, Shanghai Junshi Biosci, Eli Lilly

http://clinicaltrials.gov/ct2/show/NCT05167279

Aug 1, 2023